Under construction – not a live service
Sign in
Not yet taking people in TaiwanNo phase

Tests a podcast program for young people with type 1 diabetes moving into adulthood

Tests an online podcast program to help teens and young adults with type 1 diabetes.

Plain-language title generated from the registry record
Registry title: Efficacy of the "Living With Type 1 Diabetes to Grown-Up" Interactive Podcast Program

Key facts

Where
Taoyuan, TaiwanSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 16 and 25 years old?

Source: NCT06464640, who can take part

Where in Taiwan

  • Chang-Gung University and Chang-Gung Memorial HospitalTaoyuan, TaiwanNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Chang Gung University
Trial code
NCT06464640
Record updated
15 October 2024
Original description
The present study aims to evaluate the intervention effectiveness of the Online Interactive Podcast Program"Living with Type 1 Diabetes to Grown-Up"in patients with type 1 diabetes transitioning from adolescence to early adulthood.Read full original descriptionShow less

Efficacy of the Interactive Podcast Program "Living With Type 1 Diabetes to Grown-Up": A Two-arm Randomized Controlled Trial

The present study aims to evaluate the intervention effectiveness of the Online Interactive Podcast Program"Living with Type 1 Diabetes to Grown-Up"in patients with type 1 diabetes transitioning from adolescence to early adulthood.

Inclusion: a confirmed diagnosis of T1D by an endocrinologist before the age of 16 and a disease duration of >6months; patients aged 16-25 years; mean HbA1C level ≥7.5% one year before inclusion; ability to communicate in Chinese or Mandarin; patients who own smartphones with internet access; patients who agreed to voice recording during a session explaining the treatment process; patients who signed the informed consent form prior to participation; for minors, a legal representative must provide consent and sign the informed consent form.

Exclusion: # T1D patients with other concomitant metabolic diseases, chromosomal aberrations, major illnesses, and cognitive impairment will be excluded from this study.

ClinicalTrials.gov NCT06464640